Matrix Metalloproteinase 9 - Pipeline Review, H2 2020

1
Matrix Metalloproteinase 9 - Pipeline Review, H2
2020
Published on 23 nov 2020
2
Report Overview
Matrix Metalloproteinase 9 (Gelatinase B or 92
kDa Type IV Collagenase or 92 kDa Gelatinase or
MMP9 or EC 3.4.24.35) - Matrix metallopeptidase 9
(MMP-9) is a matrixin that belong to the
zinc-metalloproteinases family. It plays an
essential role in local proteolysis of the
extracellular matrix and in leukocyte migration
and bone osteoclastic resorption. MMP9 along with
elastase, appears to be a regulatory factor in
neutrophil migration across the basement
membrane. MMP9 may play an important role in
wound repair, angiogenesis and neovascularization.
3
Key Benefits for Matrix Metalloproteinase 9 -
Pipeline Review, H2

•  The report provides a snapshot of the global
  therapeutic landscape for Matrix
  Metalloproteinase 9 (Gelatinase B or 92 kDa Type
  IV Collagenase or 92 kDa Gelatinase or MMP9 or EC
  3.4.24.35)
•  The report reviews Matrix Metalloproteinase 9
  (Gelatinase B or 92 kDa Type IV Collagenase or 92
  kDa Gelatinase or MMP9 or EC 3.4.24.35) targeted
  therapeutics under development by companies and
  universities/research institutes based on
  information derived from company and
  industry-specific sources
•  The report covers pipeline products based on
  various stages of development ranging from
  pre-registration till discovery and undisclosed
  stages
•  The report features descriptive drug profiles
  for the pipeline products which includes, product
  description, descriptive MoA, RD brief,
  licensing and collaboration details other
  developmental activities
•  The report reviews key players involved in
  Matrix Metalloproteinase 9 (Gelatinase B or 92
  kDa Type IV Collagenase or 92 kDa Gelatinase or
  MMP9 or EC 3.4.24.35) targeted therapeutics and
  enlists all their major and minor projects

4
Market Size
Download Free Sample
Expected to reach xx million USD by the end of
Forecast year
2026
2020
Base year
CAGR xx (2020 - 2026)
91-8087042414 (Asia) (1) 646 781 7170
(Int'l) help_at_grandresearchstore.com
5
By Region
United States
Europe
China
Rest of the world
Japan
91-8087042414 (Asia) (1) 646 781 7170
(Int'l) help_at_grandresearchstore.com
6
Application

•  Gain strategically significant competitor
  information, analysis, and insights to formulate
  effective RD strategies
•  Identify emerging players with potentially
  strong product portfolio and create effective
  counter-strategies to gain competitive advantage
•  Identify and understand the targeted therapy
  areas and indications for Matrix
  Metalloproteinase 9 (Gelatinase B or 92 kDa Type
  IV Collagenase or 92 kDa Gelatinase or MMP9 or EC
  3.4.24.35)Identify the use of drugs for target
  identification and drug repurposing
•  Identify potential new clients or partners in
  the target demographic
•  Develop strategic initiatives by understanding
  the focus areas of leading companies

7
Download Free Sample
Get in touch
Call 91-8087042414 (Asia) (1) 646 781 7170
(Int'l) E-mail help_at_grandresearchstore.com
Sample includes

• Table Of Contents
• List of Tables Figures
• Charts
• Research Methodology

Follow Us
8
(No Transcript)